Tag: Oncology Biosimilars The path to appropriate biosimilar management by Magellan Health Insights May 10, 2021 Biosimilar, Biosimilar Management, Biosimilars, FDA, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit, Oncology Biosimilars, Specialty Pharmacy
